Session: Measuring Antimicrobial Use (Fifth Decennial International Conference on Healthcare-Associated Infections (March 18-22, 2010))

Friday, March 19, 2010: 2:00 PM-3:30 PM

Centennial I-II (Hyatt Regency Atlanta)

CME Credits: 1.50

Type: Oral

Summary: While other developed countries are able to assess antimicrobial use, data have not been generally available in the US. Additionally, the best metrics for measuring antimicrobial use remain controversial. This session will explore the approaches to obtaining use data in the EU, as well as the potential for using this information to guide appropriate utilization.

Learning Objectives:

Discuss the economics and implications of approaching antibiotics as a limited national resource in an effort to guide appropriate use.
Describe the successes and challenges of using point prevalence studies to obtain antimicrobial use data from hospitals throughout the European Union (EU).
Explore the efficacy of benchmarking antimicrobial use as a means of improving utilization in healthcare settings.

Co-Organized by:

Society of Infectious Diseases Pharmacists (SIDP)

Moderators:

David Schwartz, MD and Melinda Nehauser, PharmD

2:00 PM

339

Using Economic Principles to Guide Appropriate Use of Antimicrobials
Ramanan Laxminarayan, PhD, MPH, Center for Disease Dynamics, Economics and Policy (CDDEP)

2:30 PM

340

Using Point Prevalence Surveys to Measure Antimicrobial Use: The EU Model
Herman Goossens, MD, PhD, University Hospital of Antwerp

3:00 PM

341

Can Benchmarking Be Used to Improve Antimicrobial Use?
Ronald Polk, PharmD, Virginia Commonwealth University

43 Measuring Antimicrobial Use